Technologies

time icon June 9, 2015

Preclinical models for drug development in human prostate cancer

Technology description

ERASMUS MC has developed an unique set of tools for the study of human prostate cancer, which include cell lines, patient-derived xenografts and 3D cultures.

Prostate cancer is the second most common cancer in men worldwide.Prostate cancer is the second most common cancer in men worldwide. Erasmus MC has developed various experimental models systems to perform preclinical research in human prostate cancer. All materials are ready to use. The materials comprise:

- Patient-derived xenografts (PDX) and 3D cultures

- Spontaneous metastatic model

- Co-culture model

- Castration-resistant prostate cancer (CRPC) cell lines

- Human prostate cancer cell lines

References

Marqueset al.High efficacy of combination therapy using PI3K/AKT inhibitors with androgen deprivation in prostate cancer preclinical models(2015) European Urology 67(6):1177-85.

van Weerdenet al.Human xenograft models as useful tools to access the potential of novel therapeutics in prostate cancer(2009) British Journal of Cancer 100:13-18.

Application area

· Sensitive models to study prostate cancer

· Research tool to identify and elucidate signaling molecular pathways and new targets

· Drug development by allowing screening and validation of candidate drugs

These tools may ultimately facilitate the
-development of new drugs for the treatment of prostate cancer
.

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Categories
  • Information technology
  • Urology
Keywords:

experimental models systems

perform preclinical research

van weerdenet al

human xenograft models

spontaneous metastatic model

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo